Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-2 and SARS-CoV, with the potential for use in the treatment of COVID-19 disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194941 | PMC |
| http://dx.doi.org/10.1016/j.ijantimicag.2020.105969 | DOI Listing |
Publication Analysis
Top Keywords
drug repositioning
8
repositioning alternative
4
alternative treatment
4
treatment coronavirus
4
coronavirus covid-19
4
covid-19 extreme
4
extreme current
4
current pandemic
4
pandemic caused
4
caused covid-19
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!